RI
RTW Investments’s Tarsus Pharmaceuticals TARS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126M | Sell |
3,111,680
-204,352
| -6% | -$8.28M | 1.8% | 20 |
|
|
2025
Q1 | $170M | Buy |
3,316,032
+79,483
| +2% | +$4.08M | 2.61% | 15 |
|
|
2024
Q4 | $179M | Sell |
3,236,549
-175,937
| -5% | -$9.74M | 2.71% | 14 |
|
|
2024
Q3 | $112M | Hold |
3,412,486
| – | – | 1.62% | 26 |
|
|
2024
Q2 | $92.8M | Buy |
3,412,486
+140,145
| +4% | +$3.81M | 1.44% | 25 |
|
|
2024
Q1 | $119M | Buy |
3,272,341
+120,000
| +4% | +$4.36M | 1.76% | 22 |
|
|
2023
Q4 | $63.8M | Buy |
3,152,341
+271,640
| +9% | +$5.5M | 1% | 28 |
|
|
2023
Q3 | $51.2M | Buy |
2,880,701
+332,576
| +13% | +$5.91M | 1.08% | 24 |
|
|
2023
Q2 | $46M | Hold |
2,548,125
| – | – | 0.88% | 28 |
|
|
2023
Q1 | $32M | Hold |
2,548,125
| – | – | 0.67% | 30 |
|
|
2022
Q4 | $37.4M | Buy |
2,548,125
+524,946
| +26% | +$7.7M | 0.76% | 30 |
|
|
2022
Q3 | $34.6M | Buy |
2,023,179
+9,578
| +0.5% | +$164K | 0.8% | 35 |
|
|
2022
Q2 | $29.4M | Hold |
2,013,601
| – | – | 0.76% | 34 |
|
|
2022
Q1 | $33.9M | Hold |
2,013,601
| – | – | 0.7% | 41 |
|
|
2021
Q4 | $45.3M | Hold |
2,013,601
| – | – | 0.66% | 48 |
|
|
2021
Q3 | $43.4M | Hold |
2,013,601
| – | – | 0.65% | 43 |
|
|
2021
Q2 | $58.4M | Sell |
2,013,601
-450,000
| -18% | -$13M | 0.88% | 32 |
|
|
2021
Q1 | $79.1M | Hold |
2,463,601
| – | – | 1.23% | 29 |
|
|
2020
Q4 | $99M | Buy |
+2,463,601
| New | +$99M | 1.66% | 17 |
|